Member Info for Mikemine

I thought issuing options at 50p was a bit cheeky, as the SP was about that at the time, but this is just taking the proverbials. To my mind options were an incentive to add value to the company over a period of time. This will enable options to be issued at any value IES likes to guarantee free money without adding a penny to shareholder value. That's not an incentive. That's snouts in the trough. It also shows a distinct lack of faith in the future of the company by the BOD.

I admit that I don't read all that is posted here but I've not read anything about the potential of further production wells in HUR's acreage. There must be a wealth of knowledge about drilling and production from these fractured areas by now. Can any value be attached to this potential?

Have you taken in to account the batteries that were in inventory(already built and paid for)that are now due to be delivered, recent orders, and paid for? Some of these orders had part payments already attached but the balances will be added to cash balances at some stage in the near future.

As somebody said to me "It's just as important to establish a payments pathway as it is to get your product accepted." RENX have established pathways with various organisations, now Medicare, so any growth will mean paid for revenue and good cashflow. We now need to see growth of acceptance and use which I see as low take off but growing steadily as clinicians see how useful to them the test is. It's not so much about a growing number of tests as the growth in the number of clinicians. Growth of test will organically follow and therefore paid revenue as well. The sales graph will not be a straight line but will show an acceleration. That's how i see it anyway.

I stand Corrected Hawker. Silly mistake. It actually makes the RNS even better.

I really don't know what impresses the market these days. Not just Trellus but other companies I've looked at. In previous markets good news has prompted an uplift in valuation but it seems those days have temporarily gone. Trellus has two very positive RNSs and has been marked down on both occasions. I think I'll hibernate for 6 months. It would save on electricity at least.

Can only agree. The Market in general is carp but the behaviour with the last 2 RNSs is bizarre. The BOD must be tearing their hair out not to mention us. What have they got to do to get the SP up.

This RNS mentions 16,000 patients being dealt with in this programme and TRLS only needs 8,000 to break even.

Another sale so the BOD are making good on their presentation promise.

It's small, obviously a paid for pilot installation, but the significance is who they have sold to and lithium has not been chosen. It's a huge company and their buying power is immense. There are still quite a few orders in the pipeline it looks like and IES look like they are closing them.

I know it is not that reliable but, judging by the amount of blue trades, it looks like some fairly hefty buys have come in today.

From a personal perspective, I feel more comfortable this morning.

The presentation indicated that IES were not looking for more funds and the comment on the VSA cast backed this up, so no bankruptcy which had been playing on my mind.

We have a small order this morning which might be the first of a flow of news. This at least verifies what Larry was saying in the presentation. It's small but significant as it was won against completion and not subject to a grant etc. It also show the BOD was not lying. Up to now, I had the nagging feeling that the BOD were either con-men, fantasists, incompetent or frustrated. I know believe they are frustrated.

The last one is that I feel it is highly likely that IES will be the chosen supplier to the Indian project. They have to get through the funding issue that will decided on 12th October but this is just the sort of project that the Californians are looking for so I think it's odds on to be granted.

Lots of other hurdles to the SP gaining traction but I now have a better feeling.

On top of what VSA said about a big VFB order coming for somebody( nod, nod, wink wink), the guy said there was no indication that IES was preparing to look for more funding and he had been on their last one so he would know.

It's a small order but it has been gained against competition and without subsidies, grants etc. To me that's indicative. The acknowledgement that Lithium has fire potential is clear in the RNS and played a part in the decision making.

I haven'y investigated the purchasing company yet but Harper alludes to more opportunities in this area and I must agree that it gives IES a bigger shout.

There's more to this RNS than just the size of the order. Hopefully this is the start of closing the other orders.

Nearly 1mn shares sold.

Don't know if this has been flagged before but OPEC has said it's members will cut production by 2mnb per day to increase the price of crude. Biden didn't like it.

Pretty solid buying today. I'm surprised that the SP hasn't been jacked up more in view of this. It looks like lots of profit takers were around yesterday but fewer today. If you want to take a profit go right ahead but I'm waiting 3-6 months personally.

Fair few trades today comparatively. It very much depends on how you viewed the presentation and what it contained but if they start delivering on closing down those contracts this could be the easiest 100% gain you'll encounter. Well underpriced if it comes good but there's always that "if".

2P?? IES have a news drought as stated in the presentation but, if they follow through with closing some of the late stage deals, the SP will rise. That's not a great insight on my part just a pretty obvious outcome I would have thought. 2P would indicate a total collapse of the company with no sales and no money in the bank. Is that likely with what they were saying in the presentation? You'd have to make your own mind up about that but I don't see it.

Inevitable profit taking today and good luck to them but longer term this should be on an upward trajectory IMHO.

As far as I know the AIM market has less stringent criteria for listing in the way of profitability, shorter history etc but I'm no expert. Also the AIM is quite mature and fairly liquid.

TRLS is spin off from Mt Sinai and follows 2 of their other companies RENX and VRCI on to AIM so I suppose they were happy with the process. The other 2 are potential blockbusters but the Market has slaughtered their SPs, similar to what happened to TRLS. If the companies get it right they look like multi-baggers to me.

You use 5% but even if the figure is only 1%, that's still 30,000 patients and, as you say, the B/E is 7,000. Personally, in view of the acceptance mooted by Marla, I can't believe that the figure will not be way north of 1%.

I've just seen the video and I've rarely seen one like it. I couldn't find fault in any of it and the enthusiasm of Marla was quite infectious. Not surprised the SP has responded thus. I don't where the SP is going but it's going to be multiple.